Loading data for OBX — first visit, this takes a few seconds.
Obsidian Therapeutics Inc... (OBX)
NasdaqCM: OBX
· Echtzeitkurs · USD
19.95
+2.41 (13.74%)
Zum Schluss: Aug 18, 2026, 8:00 PM
Obsidian Therapeutics Inc. (OBX) Stock Price, Analysis & Data
13.74% (1D)
Keine Daten verfügbar
| Geld | n/a |
| Marktkapitalisierung | 1.23 Mrd |
| Umsatz (TTM) | n/a |
| Nettogewinn (TTM) | -95.25 Mio |
| Beta | 2.64 |
| EPS (ttm) | -1.55 |
| KGV (TTM) | n/a |
| Forward-KGV | -9.37 |
| KBV (TTM) | -1.52 |
| KUV (TTM) | n/a |
| Earnings Date | n/a |
| Brief | n/a |
| Volumen | 112,138 |
| Ø Vol. (20D) | 35,682 |
| Eröffnung | 19.26 |
| Vortagesschluss | 17.54 |
| Tagesspanne | 17.12 - 20.19 |
| 52-Wk Range | 14.57 - 49.97 |
| Analyst | n/a |
| Kursziel | n/a |
| Dividenden | n/a |
| Ex-Dividenden-Datum | n/a |
Über OBX
Obsidian Therapeutics, Inc. operates as a clinical-stage biotechnology company developing engineered cell and gene therapies. The company is developing investigational therapies, including OBX-115, which is being evaluated in clinical trials for advanced solid tumors, advanced melanoma, and relapsed refractory non-small cell lung cancer. It utilizes a proprietary Cytodriver technology platform designed to regulate protein function using FDA-appro...
Branche Biotechnology
Sektor Healthcare
IPO Datum Jul 27, 2026
Mitarbeiter 71
Börse NasdaqCM
Tickersymbol OBX
Website https://obsidiantx.com
Finanzielle Entwicklung
Im Jahr 2025 betrug der Umsatz von Obsidian Therapeutics 0, ein Anstieg von undefined% im Vergleich zum Vorjahr (0). Der Gewinn lag bei -100.61 Mio, ein Anstieg von 21.05 %.
Finanzberichte
